EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pharmacist-led management of suspected drug-provoked seizures and sequential antiseizure medication adverse reactions: a case report

Mimi Wang, You Wu, Xilin Xin, Zhangxuan Shou, Jueyi Pan

Frontiers in Pharmacology · 29.06.2026 · 17

DOI: 10.3389/fphar.2026.1853932 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.06.2026. Verfasst von Mimi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-provoked seizures constitute a clinically significant yet frequently underappreciated complication of pharmacotherapy, particularly among patients receiving antimicrobial agents with established seizurogenic potential. The subsequent management of sequential adverse drug reactions (ADRs) arising from antiseizure medication (ASM) use introduces additional pharmacological and clinical complexity. Case Summary A 73-year-old man with a remote history of epilepsy, moderate chronic kidney disease (CKD), and decade-long anticonvulsant self-discontinuation experienced two generalised tonic-clonic seizures during sleep on completion of a five-day course of intravenous moxifloxacin 0.4 g once daily and intravenous diprophylline 0.5 g twice daily for an acute COPD exacerbation. The clinical pharmacist identified the events as consistent with suspected drug-provoked seizures, hypothesising that renal impairment-driven diprophylline accumulation may have acted as a pharmacokinetically amplified pro-convulsant mechanism; as serum diprophylline concentrations were not measured, this mechanism is proposed as hypothesis-generating rather than established. Three sequential ASM-associated ADRs were subsequently detected and managed through proactive pharmacist-led pharmacovigilance: suspected sodium valproate-induced rhabdomyolysis (Naranjo score 8; confounded by post-ictal rhabdomyolysis and concurrent statin use), symptomatic oxcarbazepine-induced hyponatraemia requiring drug substitution, and suspected levetiracetam-associated hepatotoxicity not fulfilling formal drug-induced liver injury (DILI) criteria.

Conclusion

This case underscores the indispensable role of clinical pharmacist engagement in identifying suspected drug-provoked seizures, applying structured causality assessment in the presence of competing confounders, and systematically managing complex, sequential ASM-related adverse reactions in high-risk patients.

Schlagwörter

Stichwörter der Autor:innen

clinical pharmacistdiprophyllinedrug-provoked seizurepharmacovigilancerenal impairment

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Neurology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

Zitieren

APA

Wang, M., Wu, Y., Xin, X., Shou, Z., & Pan, J. (2026). Pharmacist-led management of suspected drug-provoked seizures and sequential antiseizure medication adverse reactions: a case report. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1853932

Vancouver

Wang M, Wu Y, Xin X, Shou Z, Pan J. Pharmacist-led management of suspected drug-provoked seizures and sequential antiseizure medication adverse reactions: a case report. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1853932

BibTeX
@article{Wang2026,
  author = {Wang, Mimi and Wu, You and Xin, Xilin and Shou, Zhangxuan and Pan, Jueyi},
  title = {Pharmacist-led management of suspected drug-provoked seizures and sequential antiseizure medication adverse reactions: a case report},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1853932}
}
Kostenlos starten →